HEPARIN - MECHANISM OF ACTION, PHARMACOKINETICS, DOSING CONSIDERATIONS, MONITORING, EFFICACY, AND SAFETY

被引：42

作者：

HIRSH, J

DALEN, JE

DEYKIN, D

POLLER, L

机构：

[1] UNIV ARIZONA, COLL MED, TUCSON, AZ 85721 USA

[2] VET ADM MED CTR JAMAICA PLAIN, BOSTON, MA 02130 USA

[3] WITHINGTON HOSP, NAT REFERENCE LAB ANTICOAGULANT REAGENT & CONTROL, MANCHESTER M20 8LR, LANCS, ENGLAND

来源：

CHEST | 1992年 / 102卷 / 04期

关键词：

D O I：

10.1378/chest.102.4.337S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：S337 / S351

页数：15

共 225 条

[131]

Lane D. A., 1989, HEPARIN CHEM BIOL PR, P363

[132] ANTICOAGULANT ACTIVITIES OF HEPARIN OLIGOSACCHARIDES AND THEIR NEUTRALIZATION BY PLATELET FACTOR-4 [J].

LANE, DA ;

DENTON, J ;

FLYNN, AM ;

THUNBERG, L ;

LINDAHL, U .

BIOCHEMICAL JOURNAL, 1984, 218 (03) :725-732

[133]

LANE DA, 1986, J BIOL CHEM, V261, P3980

[134]

LASTER J, 1987, SURGERY, V102, P763

[135]

LECHEY D, 1981, JAMA-J AM MED ASSOC, V246, P2189

[136]

LECLERC J, 1991, THROMB HAEMOSTASIS, V65, P753

[137] TREATMENT OF HEPARIN-ASSOCIATED THROMBOCYTOPENIA AND THROMBOSIS WITH LOW-MOLECULAR WEIGHT HEPARIN (CY-216) [J].

LEROY, J ;

LECLERC, MH ;

DELAHOUSSE, B ;

GUEROIS, C ;

FOLOPPE, P ;

GRUEL, Y ;

TOULEMONDE, F .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1985, 11 (03) :326-329

[138]

Levine M, 1989, HEPARIN CHEM BIOL PR, P517

[139] PREVENTION OF DEEP-VEIN THROMBOSIS AFTER ELECTIVE HIP-SURGERY - A RANDOMIZED TRIAL COMPARING LOW-MOLECULAR-WEIGHT HEPARIN WITH STANDARD UNFRACTIONATED HEPARIN [J].

LEVINE, MN ;

HIRSH, J ;

GENT, M ;

TURPIE, AG ;

LECLERC, J ;

POWERS, PJ ;

JAY, RM ;

NEEMEH, J .

ANNALS OF INTERNAL MEDICINE, 1991, 114 (07) :545-551

[140] NONHEMORRHAGIC COMPLICATIONS OF ANTICOAGULANT-THERAPY [J].

LEVINE, MN .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1986, 12 (01) :63-66

← 9 10 11 12 13 14 15 16 17 18 →